chr4-158703540-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004453.4(ETFDH):c.1234G>T(p.Glu412*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,609,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004453.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- multiple acyl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ETFDH | NM_004453.4 | c.1234G>T | p.Glu412* | stop_gained | Exon 10 of 13 | ENST00000511912.6 | NP_004444.2 | |
| ETFDH | NM_001281737.2 | c.1093G>T | p.Glu365* | stop_gained | Exon 9 of 12 | NP_001268666.1 | ||
| ETFDH | NM_001281738.1 | c.1051G>T | p.Glu351* | stop_gained | Exon 8 of 11 | NP_001268667.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ETFDH | ENST00000511912.6 | c.1234G>T | p.Glu412* | stop_gained | Exon 10 of 13 | 1 | NM_004453.4 | ENSP00000426638.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251160 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.0000460 AC: 67AN: 1457186Hom.: 0 Cov.: 28 AF XY: 0.0000510 AC XY: 37AN XY: 725292 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328 show subpopulations
ClinVar
Submissions by phenotype
Multiple acyl-CoA dehydrogenase deficiency Pathogenic:3Other:1
Variant classified as Pathogenic and reported on 05-29-2015 by GeneDx. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.
This sequence change creates a premature translational stop signal (p.Glu412*) in the ETFDH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ETFDH are known to be pathogenic (PMID: 16510302, 23785301). This variant is present in population databases (rs398124151, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with glutaric aciduria type 2 (Invitae). ClinVar contains an entry for this variant (Variation ID: 95071). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:2
Observed in the heterozygous state, or with a second ETFDH variant, in multiple patients with features of multiple acyl-CoA dehydrogenase deficiency who were tested at GeneDx or reported in the published literature (PMID: 29453417, 31904027); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31904027, 29453417)
Other rare neuromuscular disorders Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at